HLB Liver Cancer Drug FDA (HLB 간암 신약 FDA)Compare →
Last 30 days: first seen Nov 4 · 1h on the board · best rank #5
No per-source breakdown for this snapshot yet — it fills in from the next refresh.
Picked up by ZUM Issue Trend only — may be platform-internal dynamics.
Sample — 1 cross-checked sources · 12 snapshots (5-min interval)
Not on the board right now — here's the record of when it was.
«HLB 간암 신약 FDA» first surfaced on November 4, 2026, held the board for 1h over the last 30 days, peaking at #5. The driver: “HLB Liver Cancer Drug Enters U.S. FDA Full Review… Approval Decision to be Made on April 9 Next Year”. Currently off the board.
Why it's trending
HLB Liver Cancer Drug Enters U.S. FDA Full Review… Approval Decision to be Made on April 9 Next Year— IT조선
This is an actual headline, quoted as-is — never summarized or generated.
Related video
HLB 간암 신약 FDA
HLB, 간암 신약 FDA 문턱서 좌절…효능·안전성 문제 아니다
A YouTube video found by searching this keyword.
Related coverage
·
HLB 간암 신약 FDA first appeared on KoreaTrendBoard on November 4, 2026. It has been observed 12 times since, peaking at rank 5 with a score of 35.8. It was last seen on November 4, 2026.
Rose alongside
Times they appeared on the same board snapshot in the last 7 days. Three or more only — once or twice is chance.
Loading
This chart shows the last 14 days. Pro opens 180 days and lets you export the same data as CSV — one row per day with rank, score and source count. See what opens →
Rose alongside
The number is how many times it appeared on the board at the same moment as this keyword, over the last 7 days.
The full board on 2026-11-04 → · This week · Glossary
Picked up by: ZUM Issue TrendReferenced from each site's publicly available rankings. No affiliation or partnership.
Want a heads-up when «HLB 간암 신약 FDA» climbs again? It's free.
No signup form — your email is the account. One click to stop.
- 180-day history — the curve, not the moment
- Alerts — pinged within 5 minutes when your keyword moves
- API — ranks and scores straight into your report